Inflammatory cardiomyopathy

Hellenic Journal of Cardiology

Volumn 47, Issue 2, 2006, Pages 54-65

  Karatolios, Konstantinos ^a   Pankuweit, Sabine ^a   Kisselbach, Christiane ^a   Maisch, Bernhard ^a,b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Immunohistochemistry; Inflammatory cardiomyopathy; Polymerase chain reaction; Viral infection

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; IMMUNOGLOBULIN;

ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HUMAN; MYOCARDITIS; POLYMERASE CHAIN REACTION; WORLD HEALTH ORGANIZATION;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDITIS; MYOCARDIUM;

EID: 33646885237     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Richardson P, McKenna W, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
2. Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Br Heart J 1980; 44: 672-673.
3. Maisch B, Portig I, Ristic AD, et al: Definition of inflammatory cardiomyopathy myocarditis: on the way to consensus - a status report. Herz 2000; 25: 200-209.
4. Mattingly TW: Changing concepts of myocardial disease. JAMA 1965; 191: 127-131.
5. Feldman AM, McNamara D: Medical progress: myocarditis. N Engl J Med 2000; 343: 1388-1398.
6. Drory Y, Turetz Y, Hiss Y, et al: Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68: 1388-1392.
7. Mason JW: Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol 1978; 41: 887-892.
8. Aretz HT, Billingham ME, Edwards WD, et al: Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.
9. Anandasabapathy S, Frishman WH: Innovative drug treatments for viral and autoimmune myocarditis. J Clin Pharmacol 1998; 38: 295-308.
10. Liu P, Martino T, Opavsky MA, et al: Viral myocarditis: balance between viral infection and immune response. Can J Cardiol 1996; 12: 935-943.
11. Pankuweit S, Baandrup U, Moll R, et al: Prevalence of parvovirus B19 genome in endomyocardial biopsy specimen. Hum Pathol 2003; 34: 80-86.
12. Kühl U, Pauschinger M, Bock T, et al: Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003; 108: 945-950.
13. Baboonian C, Treasure T: Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997; 78: 539-543.
14. Bowles NE, Richardson PJ, Olsen EGJ, et al: Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986; 1: 1120-1123.
15. Grumbach IM, Heim A, Pring-Akerblom, et al: Adenoviruses and enteroviruses as pathogen in myocarditis and dilated cardiomyopathy. Acta Cardiol 1999; 54: 83-88.
16. Maisch B, Schönian U, Crombach M, et al: Cytomegalovirus associated inflammatory heart muscle disease. Scand J Infect Dis 1993; 88: 135-148.
17. Cambridge G, MacArthur CG, Waterson AP, et al: Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J 1979; 41: 692-696.
18. Schwaiger A, Umlauft F, Weyrer K, et al: Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am Heart J 1993; 126: 406-410.
19. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al: Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999; 99: 1348-1354.
20. Maisch B, Bültman, Factor S, et al: World Heart Federation consensus conferences' definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 1999; 4: 3-4.
21. Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S; BMBF-Heart Failure Network: Inflammatory dilated cardiomyopathy (DCMI). Herz 2005; 30: 535-544.
22. Gauntt C, Tracy C, Chapman N, et al: Coxsackie virus-induced chronic myocarditis in murine models. Eur Heart J 1995; 16 (suppl O): 56-58.
23. Huber SA, Cunningham MW: Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against Coxsackie viral myocarditis. J Immunol 1996; 156: 3528-3534.
24. Kasahara H, Itoh M, Sugiyama T, et al: Autoimmune myocarditis induced in mice by cardiac C-protein: cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest 1994; 94: 1026-1036.
25. Pummerer CL, Grassl G, Sailer M, et al: Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. Lab Invest 1996; 74: 845-852.
26. Liu PP, Mason JW: Advances in the understanding of myocarditis. Circulation 2001; 104: 1076-1082.
27. Mason JW: Myocarditis and dilated cardiomyopathy: An inflammatory link. Cardiovasc Res 2003; 60: 5-10.
28. McCarthy RE 3rd, Boehmer JP, Hruban RH, et al: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-695.
29. Binah O: Cytotoxic lymphocytes and cardiac electrophysiology. J Mol Cell Cardiol 2002; 34: 1147-1161.
30. Maisch B, Ristic A, Hufnagel G, et al: Pathophysiology of viral myocarditis. The role of humoral immune response. Cardiovasc Pathol 2002; 11: 112-122.
31. Pankuweit S, Ruppert V, Maisch B: Inflammation in dilated cardiomyopathy. Herz 2004; 29: 788-793.
32. Seder R, Gazzinelli AP, Sher A, et al: Interleukin-12 acts directly on CD4+ T-cells to enhance priming for IFN- production and diminishes Interleukin-4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-10192.
33. Pankuweit S, Portig I, Maisch B, et al: Pathophysiology of cardiac inflammation: Molecular mechanisms. Herz 2002; 27: 669-676.
34. Schwimmbeck PL, Badorff C, Schultheiss HP, et al: Transfer of human myocarditis into severe combined immunodeficiency mice. Circ Res1994; 75: 156-164.
35. Pankuweit S, Portig I, Lottspeich F, et al: Autoantibodies in the sera of patients with myocarditis: Characterization of the corresponding antigens by isoelectric focussing and n-terminal sequence analysis. J Mol Cell Cardiol 1997; 29: 77-84.
36. Caforio AL, Mahon NJ, Tona F, et al: Circulating cardiac antibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411-417.
37. Pankuweit S, Ristic AD, Maisch B: Patophysiology and aetiological diagnosis of inflammatory myocardial and pericardial diseases: a new therapeutic concept. Cardiol Int 2005; 3: 99-103.
38. Naparstek Y, Plotz PH: The role of autoantibodies in autoimmune disease. Annu Rev Immunol 1993; 11: 79-104.
39. Maisch B: Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis. Heart Vessels 1985; 1: 209-17 (Supplement).
40. Why HJ, Meany BT, Richardson PJ, et al: Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582-2589.
41. Calabrese F, Thiene G: Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003; 60: 11-25.
42. Chow LH, Radio SJ, Sears TD, et al: Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989; 14: 915-920.
43. Hauck AJ, Kearney DL, Edwards WD: Evaluation of post-mortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989; 64: 1235-1245.
44. Burke AP, Farb A, Robinowitz M, et al: Serial sectioning and multiple level examination of endomyocardial biopsies for the diagnosis of myocarditis. Mod Pathol 1991; 4: 690-693.
45. Frustaci A, Bellocci F, Osen EG: Results of biventricular endomyocardial biopsy in survivors of cardiac arrest with apparently normal hearts. Am J Cardiol 1994; 74: 890-895.
46. Kuhl U, Pauschinger N, Noutsias M, et al: High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005; 111: 887-893.
47. Kishimoto C, Shioji K, Kinsohita M, et al: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Intern J Cardiol 2003; 91: 173-178.
48. McNamara DM, Holubkov R, Starling RC, et al, for the Intervention in Myocarditis and Acute Cardiomyopathy (IMAC) Investigators: Controlled trial of intravenous immune globuline in recent-onset dilated cardiomyopathy. Circulation 2001; 103: 2254-2259.
49. McNamara DM, Rosenblum WD, Janosko KM, et al: Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997; 95: 2476-2478.
50. Takeda Y, Yasuda S, Miyazaki S, et al: High-dose immunoglobulin G therapy for fulminant myocarditis. Jap Circ J 1998; 62: 871-872.
51. Nigro G, Bastianon V, Colloridi V, et al: Human parvovirus B19 infection in infancy with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 2000; 31: 65-69.
52. Tsai YG, Ou TY, Wang CC, et al: Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: report of one case. Acta Paediatr Taiwan 2001; 42: 311-313.
53. Shioji K, Matsuura Y, Iwase T, et al: Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thiredoxin - a case report. Circulation J 2002; 66: 977-980.
54. Tedeschi A, Liraghi L, Giannini S, et al: High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and a review of the literature. J Intern Med 2002; 251: 169-173.
55. Wang C, Luf FL, Wu M, et al: Fatal Coxsackie virus A16 infection. Pediatr Infect Dis J 2004; 23: 275-276.
56. Drucker NA, Colan SD, Lewis AB, et al: Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252-257.
57. Maisch B, Pankuweit S, Funck R, et al: Effective CMV hyperimmunoglobulin treatment in CMV myocarditis - a controlled treatment trial. Eur Heart J 2004; 25: Abstract Suppl: 114, P674.
58. Maisch B, Schoenian U, Crombach M, et al: Cytomegalovirus associated inflammatory heart muscle disease. Scand J Infect Dis Suppl 1993; 88: 135-148.
59. Maisch B, Hufnagel G, Kolsch S, et al: Treatment of inflammatory dilated cardiomyopathy and (peri) myocarditis with immunosuppression and i.v. immunoglobulins Herz 2004; 29: 624-636.
60. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: 2 years follow-up results. Circulation 2001; 104: 39-45.
61. Mason JW: Immunopathogenesis and treatment of myocarditis: The United States Myocarditis Treatment Trial. J Card Fail 1996;2:Suppl 4;s173-177.
62. Mason JW, O'Connel JB, Hershkowitz A, et al: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Eng J Med 1995; 33: 269-275.
63. Hufnagel G, Pankuweit S, Richter A, et al: The European Study on the Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000; 25: 279-285.
64. Maisch B, Hufnagel G, Schoenian U, et al: The European Study on the Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). Eur Heart J 1995; 16 (Suppl O): 173-175.
65. Müller J, Wallukat G, Dandel M, et al: Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391.
66. Wallukat G, Müller J, Hetzer R: Specific removal of beta1-adrenergic autoabtibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 2002; 347: 1806.
67. Frustaci A, Chimenti C, Calabrese F, et al: Immunosuppressive therapy for active lymphocytic myocarditis. Virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-863.
68. Kühl U, Pauschinger M, Schwimmbeck PL, et al: Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003; 107: 2793-2798.
69. Alter P, Grimu W, Maisch B. Varicella myocarditis in an adult. Heart. 2001; 85: E2.